Folgen
Prof. Denis Xavier MD, MSc
Prof. Denis Xavier MD, MSc
Vice Dean (PG), Professor Pharmacology, Head, Div of Clinical Research, St. John's Medical College
Bestätigte E-Mail-Adresse bei sjri.res.in
Titel
Zitiert von
Zitiert von
Jahr
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
38290*2016
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S Ôunpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
The lancet 364 (9438), 937-952, 2004
153842004
Dabigatran versus warfarin in patients with atrial fibrillation
SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ...
New England Journal of Medicine 361 (12), 1139-1151, 2009
131252009
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic …
MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ...
The lancet 388 (10053), 1659-1724, 2016
8738*2016
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of …
T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ...
The lancet 388 (10053), 1545-1602, 2016
7862*2016
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic …
SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1789-1858, 2018
47602018
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of …
GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1736-1788, 2018
41432018
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global …
H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ...
The lancet 388 (10053), 1459-1544, 2016
40202016
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
MJ O'donnell, D Xavier, L Liu, H Zhang, SL Chin, P Rao-Melacini, ...
The Lancet 376 (9735), 112-123, 2010
38022010
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ...
The lancet 390 (10100), 1151-1210, 2017
37192017
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial
POISE Study Group
The Lancet 371 (9627), 1839-1847, 2008
23082008
American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ...
Heart disease and stroke statistics-2018 update: a report from the American …, 2018
22732018
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
SS Jolly, S Yusuf, J Cairns, K Niemelä, D Xavier, P Widimsky, A Budaj, ...
The Lancet 377 (9775), 1409-1420, 2011
22422011
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
MJ O'Donnell, SL Chin, S Rangarajan, D Xavier, L Liu, H Zhang, ...
The lancet 388 (10046), 761-775, 2016
15472016
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
14212019
Comparison of fondaparinux and enoxaparin in acute coronary syndromes
Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ...
New England Journal of Medicine 354 (14), 1464-1476, 2006
13992006
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 …
HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1859-1922, 2018
13932018
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 …
SI Hay, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ...
The Lancet 390 (10100), 1260-1344, 2017
12742017
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1238-1251, 2008
11852008
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction-The OASIS-6 randomized trial
S Yusuf, SR Mehta, S Chrolavicius, R Afzal, J Pogue, CB Granger, ...
Journal of the American Medical Association 295 (13), 1519-1530, 2006
10752006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20